Investigating how cell processes affect insulin-producing cells in diabetes
Autophagy/antioxidant response coupling in pancreatic beta-cell homeostasis regulation
This study is looking at how certain harmful substances can damage the insulin-producing cells in the pancreas, which is important for people with Type 1 diabetes, and it’s exploring ways to help protect these cells and keep them healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-11039950 on NIH RePORTER |
What this research studies
This research focuses on understanding the mechanisms behind the death of insulin-producing beta cells in the pancreas, which is a key factor in the development of Type 1 diabetes. The study examines how reactive oxygen species (ROS) contribute to beta cell damage and explores the role of a specific transcription factor, NRF2, in protecting these cells. By coupling autophagy, a process that cleans up damaged cellular components, with antioxidant responses, the research aims to enhance beta cell survival. The approach includes both laboratory experiments with cultured cells and studies in live mice to validate findings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for Type 1 diabetes or those with early signs of beta cell dysfunction.
Not a fit: Patients with Type 2 diabetes or those whose diabetes is not related to beta cell apoptosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating Type 1 diabetes by protecting insulin-producing cells.
How similar studies have performed: Previous research has shown promising results in protecting beta cells through antioxidant mechanisms, suggesting that this approach may be effective.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Linnemann, Amelia K — Indiana University Indianapolis
- Study coordinator: Linnemann, Amelia K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.